FDA limits use of risky Sanofi antibiotic Ketek
Mon, 12 Feb 2007 04:17 PM EST
... WASHINGTON (Reuters) - U.S. regulators warned on Monday that Sanofi-Aventis SA's antibiotic Ketek should no longer be used to treat patients with sinusitis and bronchitis, saying the controversial drug carries too many risks. ...
Related Topics
- Telithromycin
- Antibiotics
- Hydrocortisone, Neomycin, and Polymyxin Otic
- Carcinogens
- Antibiotic Resistance
- Tacrolimus ointment
- Mammography
- Pimecrolimus Cream 1%
- Dietary Guidelines
- Antibiotic-associated diarrhea
- Thalidomide
- Polymyxin B, Bacitracin, and Neomycin
- Cefuroxime
- Cephalexin
- Viral Infections
- Sulfamethoxazole and Trimethoprim
- Food Labeling
- Streptomycin
- Drug Safety
- Yohimbe

Not Signed In -


